Establishment of a simple cell-based ELISA for the direct detection of abnormal isoform of prion protein from prion-infected cells without cell lysis and proteinase K treatment

REFERENCES

• Aguzzi A, Baumann F, Bremer J. The prion's elusive reason for being. Annu Rev Neurosci 2008; 31:439-77; PMID:18558863; http://dx.doi.org/10.1146/annurev.neuro.31.060407.125620
   PubMed Web of Science ®Google Scholar
• Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B. The most infectious prion protein particles. Nature 2005; 437:257-61; PMID:16148934; http://dx.doi.org/10.1038/nature03989
   PubMed Web of Science ®Google Scholar
• Wang F, Wang X, Yuan CG, Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010; 327:1132-5; PMID:20110469; http://dx.doi.org/10.1126/science.1183748
   PubMed Web of Science ®Google Scholar
• Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S, Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 2003; 302:871-4; PMID:14593181; http://dx.doi.org/10.1126/science.1090187
   PubMed Web of Science ®Google Scholar
• Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, Raymond L, Favara C, Baron G, Priola S, et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 2005; 308:1435-9; PMID:15933194; http://dx.doi.org/10.1126/science.1110837
   PubMed Web of Science ®Google Scholar
• Marijanovic Z, Caputo A, Campana V, Zurzolo C. Identification of an intracellular site of prion conversion. PLoS Pathog 2009; 5:e1000426; PMID:19424437; http://dx.doi.org/10.1371/journal.ppat.1000426
   PubMed Web of Science ®Google Scholar
• Veith NM, Plattner H, Stuermer CA, Schulz-Schaeffer WJ, Burkle A. Immunolocalisation of PrPSc in scrapie-infected N2a mouse neuroblastoma cells by light and electron microscopy. Eur J Cell Biol 2009; 88:45-63; PMID:18834644; http://dx.doi.org/10.1016/j.ejcb.2008.08.001
   PubMed Web of Science ®Google Scholar
• Caughey B, Raymond GJ. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem 1991; 266:18217-23; PMID:1680859
   PubMed Web of Science ®Google Scholar
• Taraboulos A, Raeber AJ, Borchelt DR, Serban D, Prusiner SB. Synthesis and trafficking of prion proteins in cultured cells. Mol Biol Cell 1992; 3:851-63; PMID:1356522; http://dx.doi.org/10.1091/mbc.3.8.851
   PubMed Web of Science ®Google Scholar
• Goold R, Rabbanian S, Sutton L, Andre R, Arora P, Moonga J, Clarke AR, Schiavo G, Jat P, Collinge J, et al. Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat Commun 2011; 2:281; PMID:21505437; http://dx.doi.org/10.1038/ncomms1282
   PubMed Web of Science ®Google Scholar
• Yamasaki T, Baron GS, Suzuki A, Hasebe R, Horiuchi M. Characterization of intracellular dynamics of inoculated PrP-res and newly generated PrP(Sc) during early stage prion infection in Neuro2a cells. Virology 2014; 450-451:324-35; PMID:24503096; http://dx.doi.org/10.1016/j.virol.2013.11.007
   PubMed Web of Science ®Google Scholar
• Kocisko DA, Baron GS, Rubenstein R, Chen J, Kuizon S, Caughey B. New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J Virol 2003; 77:10288-94; PMID:12970413; http://dx.doi.org/10.1128/JVI.77.19.10288-10294.2003
   PubMed Web of Science ®Google Scholar
• Ghaemmaghami S, May BC, Renslo AR, Prusiner SB. Discovery of 2-aminothiazoles as potent antiprion compounds. J Virol 2010; 84:3408-12; PMID:20032192; http://dx.doi.org/10.1128/JVI.02145-09
   PubMed Web of Science ®Google Scholar
• Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73:1339-47; PMID:8100741; http://dx.doi.org/10.1016/0092-8674(93)90360-3
   PubMed Web of Science ®Google Scholar
• White MD, Farmer M, Mirabile I, Brandner S, Collinge J, Mallucci GR. Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proc Natl Acad Sci U S A 2008; 105:10238-43; PMID:18632556; http://dx.doi.org/10.1073/pnas.0802759105
   PubMed Web of Science ®Google Scholar
• Karapetyan YE, Sferrazza GF, Zhou M, Ottenberg G, Spicer T, Chase P, Fallahi M, Hodder P, Weissmann C, Lasmezas CI. Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents. Proc Natl Acad Sci U S A 2013; 110:7044-9; PMID:23576755; http://dx.doi.org/10.1073/pnas.1303510110
   PubMed Web of Science ®Google Scholar
• Silber BM, Gever JR, Rao S, Li Z, Renslo AR, Widjaja K, Wong C, Giles K, Freyman Y, Elepano M, et al. Novel compounds lowering the cellular isoform of the human prion protein in cultured human cells. Bioorg Med Chem 2014; 22:1960-72; PMID:24530226; http://dx.doi.org/10.1016/j.bmc.2014.01.001
   PubMed Web of Science ®Google Scholar
• Kuwata K, Nishida N, Matsumoto T, Kamatari YO, Hosokawa-Muto J, Kodama K, Nakamura HK, Kimura K, Kawasaki M, Takakura Y, et al. Hot spots in prion protein for pathogenic conversion. Proc Natl Acad Sci U S A 2007; 104:11921-6; PMID:17616582; http://dx.doi.org/10.1073/pnas.0702671104
   PubMed Web of Science ®Google Scholar
• Hosokawa-Muto J, Kamatari YO, Nakamura HK, Kuwata K. Variety of antiprion compounds discovered through an in silico screen based on cellular-form prion protein structure: Correlation between antiprion activity and binding affinity. Antimicrob Agents Chemother 2009; 53:765-71; PMID:19015328; http://dx.doi.org/10.1128/AAC.01112-08
   PubMed Web of Science ®Google Scholar
• Ferreira NC, Marques IA, Conceicao WA, Macedo B, Machado CS, Mascarello A, Chiaradia-Delatorre LD, Yunes RA, Nunes RJ, Hughson AG, et al. Anti-prion activity of a panel of aromatic chemical compounds: in vitro and in silico approaches. PLoS One 2014; 9:e84531; PMID:24400098; http://dx.doi.org/10.1371/journal.pone.0084531
   PubMed Web of Science ®Google Scholar
• Tzaban S, Friedlander G, Schonberger O, Horonchik L, Yedidia Y, Shaked G, Gabizon R, Taraboulos A. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 2002; 41:12868-75; PMID:12379130; http://dx.doi.org/10.1021/bi025958g
   PubMed Web of Science ®Google Scholar
• Pastrana MA, Sajnani G, Onisko B, Castilla J, Morales R, Soto C, Requena JR. Isolation and characterization of a proteinase K-sensitive PrPSc fraction. Biochemistry 2006; 45:15710-7; PMID:17176093; http://dx.doi.org/10.1021/bi0615442
   PubMed Web of Science ®Google Scholar
• Yamasaki T, Suzuki A, Shimizu T, Watarai M, Hasebe R, Horiuchi M. Characterization of intracellular localization of PrP(Sc) in prion-infected cells using a mAb that recognizes the region consisting of aa 119-127 of mouse PrP. J Gen Virol 2012; 93:668-80; PMID:22090211; http://dx.doi.org/10.1099/vir.0.037101-0
   PubMed Web of Science ®Google Scholar
• Sakai K, Hasebe R, Takahashi Y, Song CH, Suzuki A, Yamasaki T, Horiuchi M. Absence of CD14 delays progression of prion diseases accompanied by increased microglial activation. J Virol 2013; 87:13433-45; PMID:24089559; http://dx.doi.org/10.1128/JVI.02072-13
   PubMed Web of Science ®Google Scholar
• Klingenstein R, Lober S, Kujala P, Godsave S, Leliveld SR, Gmeiner P, Peters PJ, Korth C. Tricyclic antidepressants, quinacrine and a novel, synthetic chimera thereof clear prions by destabilizing detergent-resistant membrane compartments. J Neurochem 2006; 98:748-59; PMID:16749906; http://dx.doi.org/10.1111/j.1471-4159.2006.03889.x
   PubMed Web of Science ®Google Scholar
• Caughey B, Raymond GJ. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol 1993; 67:643-50; PMID:7678300
   PubMed Web of Science ®Google Scholar
• Kim CL, Karino A, Ishiguro N, Shinagawa M, Sato M, Horiuchi M. Cell-surface retention of PrPC by anti-PrP antibody prevents protease-resistant PrP formation. J Gen Virol 2004; 85:3473-82; PMID:15483265; http://dx.doi.org/10.1099/vir.0.80113-0
   PubMed Web of Science ®Google Scholar
• Kim CL, Umetani A, Matsui T, Ishiguro N, Shinagawa M, Horiuchi M. Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies. Virology 2004; 320:40-51; PMID:15003861; http://dx.doi.org/10.1016/j.virol.2003.10.026
   PubMed Web of Science ®Google Scholar
• Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohen FE, Prusiner SB. Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 1998; 4:1157-65; PMID:9771749; http://dx.doi.org/10.1038/2654
   PubMed Web of Science ®Google Scholar
• Safar JG, Geschwind MD, Deering C, Didorenko S, Sattavat M, Sanchez H, Serban A, Vey M, Baron H, Giles K, et al. Diagnosis of human prion disease. Proc Natl Acad Sci U S A 2005; 102:3501-6; PMID:15741275; http://dx.doi.org/10.1073/pnas.0409651102
   PubMed Web of Science ®Google Scholar
• Godsave SF, Wille H, Kujala P, Latawiec D, DeArmond SJ, Serban A, Prusiner SB, Peters PJ. Cryo-immunogold electron microscopy for prions: toward identification of a conversion site. J Neurosci 2008; 28:12489-99; PMID:19020041; http://dx.doi.org/10.1523/JNEUROSCI.4474-08.2008
   PubMed Web of Science ®Google Scholar
• Heal W, Thompson MJ, Mutter R, Cope H, Louth JC, Chen B. Library synthesis and screening: 2,4-diphenylthiazoles and 2,4-diphenyloxazoles as potential novel prion disease therapeutics. J Med Chem 2007; 50:1347-53; PMID:17305326; http://dx.doi.org/10.1021/jm0612719
   PubMed Web of Science ®Google Scholar
• Leidel F, Eiden M, Geissen M, Kretzschmar HA, Giese A, Hirschberger T, Tavan P, Schatzl HM, Groschup MH. Diphenylpyrazole-derived compounds increase survival time of mice after prion infection. Antimicrob Agents Chemother 2011; 55:4774-81; PMID:21746938; http://dx.doi.org/10.1128/AAC.00151-11
   PubMed Web of Science ®Google Scholar
• Yamasaki T, Suzuki A, Hasebe R, Horiuchi M. Comparison of the anti-prion mechanism of four different anti-prion compounds, anti-PrP monoclonal antibody 44B1, pentosan polysulfate, chlorpromazine, and U18666A, in prion-infected mouse neuroblastoma cells. PLoS One 2014; 9:e106516; PMID:25181483; http://dx.doi.org/10.1371/journal.pone.0106516
   PubMed Web of Science ®Google Scholar
• Cronier S, Gros N, Tattum MH, Jackson GS, Clarke AR, Collinge J, Wadsworth JD. Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J 2008; 416:297-305; PMID:18684106; http://dx.doi.org/10.1042/BJ20081235
   PubMed Web of Science ®Google Scholar
• Wadsworth JD, Joiner S, Hill AF, Campbell TA, Desbruslais M, Luthert PJ, Collinge J. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 2001; 358:171-80; PMID:11476832; http://dx.doi.org/10.1016/S0140-6736(01)05403-4
   PubMed Web of Science ®Google Scholar
• Ishiguro N, Inoshima Y, Sassa Y, Takahashi T. Molecular characterization of chicken prion proteins by C-terminal-specific monoclonal antibodies. Vet Immunol Immunopathol 2009; 128:402-6; PMID:19118905; http://dx.doi.org/10.1016/j.vetimm.2008.11.025
   PubMed Web of Science ®Google Scholar
• Wopfner F, Weidenhofer G, Schneider R, von Brunn A, Gilch S, Schwarz TF, Werner T, Schatzl HM. Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J Mol Biol 1999; 289:1163-78; PMID:10373359; http://dx.doi.org/10.1006/jmbi.1999.2831
   PubMed Web of Science ®Google Scholar
• Horiuchi M, Mochizuki M, Ishiguro N, Nagasawa H, Shinagawa M. Epitope mapping of a monoclonal antibody specific to feline panleukopenia virus and mink enteritis virus. J Vet Med Sci 1997; 59:133-6; PMID:9070987; http://dx.doi.org/10.1292/jvms.59.133
   PubMed Web of Science ®Google Scholar
• Uryu M, Karino A, Kamihara Y, Horiuchi M. Characterization of prion susceptibility in Neuro2a mouse neuroblastoma cell subclones. Microbiol Immunol 2007; 51:661-9; PMID:17641468; http://dx.doi.org/10.1111/j.1348-0421.2007.tb03954.x
   PubMed Web of Science ®Google Scholar
• Nakamitsu S, Kurokawa A, Yamasaki T, Uryu M, Hasebe R, Horiuchi M. Cell density-dependent increase in the level of protease-resistant prion protein in prion-infected Neuro2a mouse neuroblastoma cells. J Gen Virol 2010; 91:563-9; PMID:19812263; http://dx.doi.org/10.1099/vir.0.016287-0
   PubMed Web of Science ®Google Scholar
• Schatzl HM, Laszlo L, Holtzman DM, Tatzelt J, DeArmond SJ, Weiner RI, Mobley WC, Prusiner SB. A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J Virol 1997; 71:8821-31; PMID:9343242
   PubMed Web of Science ®Google Scholar